IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia

GLIA

Volumn 58, Issue 9, 2010, Pages 1082-1093

  Baker, Brandi J ^a   Park, Keun W ^a   Qin, Hongwei ^a   Ma, Xiangyu ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Interleukin 27; Neuroinflammation; Neurotoxicity; NF B; Oncostatin M

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 27; ONCOSTATIN M; RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION; MICROGLIA; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALS; CELL DEATH; CELL LINE; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MODELS, NEUROLOGICAL; NEURONS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ONCOSTATIN M; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954391616     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20989     Document Type: Article

References (64)

1. Aggarwal BB. 2003. Signaling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3:745-756.
2. Allan SM, Rothwell NJ. 2001. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
4. Ashburner BP, Westerheide SD, Baldwin AS Jr. 2001. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21:7065-7077.
5. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN. 2009. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28:3735-3745.
6. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8:1380-1389. (Pubitemid 350131175)
7. Baker BJ, Qin H, Benveniste EN. 2008. Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes. Glia 56:1250-1262.
8. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491. (Pubitemid 32781092)
9. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7:929-936.
10. Benveniste EN, Benos DJ. 1995. TNF-alpha- and IFN-gamma-mediated signal transduction pathways: Effects on glial cell gene expression and function. FASEB J 9:1577-1584. (Pubitemid 3014761)
11. Boing I, Stross C, Radtke S, Lippok BE, Heinrich PC, Hermanns HM. 2006. Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases. Cell Signal 18:50-61.
12. Cereda C, Baiocchi C, Bongioanni P, Cova E, Guareschi S, Metelli MR, Rossi B, Sbalsi I, Cuccia MC, Ceroni M. 2008. TNF and sTNFR1/2 plasma levels in ALS patients. J Neuroimmunol 194:123-131.
13. Chen SH, Benveniste EN. 2004. Oncostatin M: A pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev 15:379-391.
14. Collart MA, Baeuerle P, Vassalli P. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10:1498-1506.
15. Combs CK, Karlo JC, Kao SC, Landreth GE. 2001. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188.
16. D'Mello C, Le T, Swain MG. 2009. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29:2089-2102.
17. Ensoli F, Fiorelli V, Lugaresi A, Farina D, De Cristofaro M, Collacchi B, Muratori DS, Scala E, Di Gioacchino M, Paganelli R, Aiuti F. 2002. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler 8:284-288.
18. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A. 2007a. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179:3268-3275.
19. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A. 2007b. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8:1372-1379.
20. Gavrilyuk V, Horvath P, Weinberg G, Feinstein DL. 2001. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 78:129-140. (Pubitemid 32622595)
21. Halfter H, Friedrich M, Postert C, Ringelstein EB, Stogbauer F. 1999. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells. Mol Cell Biol Res Commun 1:109-116. (Pubitemid 129533201)
22. He BP, Wen W, Strong MJ. 2002. Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J Neuroimmunol 128:31-38.
23. He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y. 2007. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178:829-841.
24. Hintzen C, Evers C, Lippok BE, Volkmer R, Heinrich PC, Radtke S, Hermanns HM. 2008. Box 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation. J Biol Chem 283:19465-19477.
25. Kastl SP, Speidl WS, Kaun C, Katsaros KM, Rega G, Afonyushkin T, Bochkov VN, Valent P, Assadian A, Hagmueller GW, et al. 2008. In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation. Arterioscler Thromb Vasc Biol 28:498-503.
26. Kawahara K, Yoshida A, Koga K, Yokoo S, Kuniyasu A, Gotoh T, Sawada M, Nakayama H. 2009. Marked induction of inducible nitric oxide synthase and tumor necrosis factor-alpha in rat CD40+ microglia by comparison to CD40- microglia. J Neuroimmunol 208:70-79.
27. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. 2005. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4:471-479.
28. Korzus E, Nagase H, Rydell R, Travis J. 1997. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 272:1188-1196.
29. Kuprash DV, Udalova IA, Turetskaya RL, Kwiatkowski D, Rice NR, Nedospasov SA. 1999. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J Immunol 162:4045-4052.
30. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, et al. 2009. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319-1330.
31. Lee SJ, Qin H, Benveniste EN. 2007. Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha. J Leukoc Biol 82:436-447.
32. Liang J, Lei T, Song Y, Yanes N, Qi Y, Fu M. 2009. RNA destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling. J Biol Chem 284:29383-29390.
33. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21:6461-6469.
34. McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG. 2006. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci 26:9365-9375.
35. McCoy MK, Ruhn KA, Martinez TN, McAlpine FE, Blesch A, Tansey MG. 2008. Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol Ther 16:1572-1579.
36. Nadeau S, Rivest S. 2000. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 20:3456-3468. (Pubitemid 30263162)
37. Nguyen VT, Benveniste EN. 2002. Critical role of tumor necrosis factoralpha and NF-kappa B in interferon-gamma-induced CD40 expression in microglia/macrophages. J Biol Chem 277:13796-13803.
38. Owaki T, Asakawa M, Kamiya S, Takeda K, Fukai F, Mizuguchi J, Yoshimoto T. 2006. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol 176:2773-2780. (Pubitemid 43306936)
39. Pacher P, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424.
40. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160:943-952.
41. Petrova TV, Akama KT, Van Eldik LJ. 1999. Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction. J Biol Chem 274:28823-28827.
42. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, Benveniste EN. 2006. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 177:7761-7771.
43. Repovic P, Benveniste EN. 2002. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22:5334-5343. (Pubitemid 35386455)
44. Repovic P, Fears CY, Gladson CL, Benveniste EN. 2003. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22:8117-8124.
45. Rivest S. 2009. Regulation of innate immune responses in the brain. Nat Rev Immunol 9:429-439.
46. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386.
47. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, Rieckmann P. 2001. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 60:1087-1098.
48. Saha RN, Pahan K. 2006. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8:929-947.
49. Schichl YM, Resch U, Hofer-Warbinek R, de Martin R. 2009. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J Biol Chem 284:29571-29581.
50. Selmaj K, Papierz W, Glabinski A, Kohno T. 1995. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 56:135-141.
51. Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. 2005. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res 1040:202-207.
52. Sriram K, O'Callaghan JP. 2007. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2:140-153.
53. Stumhofer JS, Hunter CA. 2008. Advances in understanding the antiinflammatory properties of IL-27. Immunol Lett 117:123-130.
54. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'shea JJ, Hunter CA. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363-1371.
55. Takata F, Sumi N, Nishioku T, Harada E, Wakigawa T, Shuto H, Yamauchi A, Kataoka Y. 2008. Oncostatin M induces functional and structural impairment of blood-brain barriers comprised of rat brain capillary endothelial cells. Neurosci Lett 441:163-166.
56. Vecchiet J, Dalessandro M, Falasca K, Di Iorio A, Travasi F, Zingariello P, Schiavone C, Ensoli F, Pizzigallo E, Paganelli R. 2003. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J Acquir Immune Defic Syndr 32:464-465.
57. Vitvitsky V, Thomas M, Ghorpade A, Gendelman HE, Banerjee R. 2006. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem 281:35785-35793.
58. Weissman BA, Gross SS. 2001. Measurement of NO, NO synthase. Curr Protoc Neurosci 5:7.131-7.1322.
59. Wen W, Sanelli T, Ge W, Strong W, Strong MJ. 2006. Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor. Neurosci Res 55:87-95.
60. Wesemann DR, Dong Y, O'Keefe GM, Nguyen VT, Benveniste EN. 2002. Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages. J Immunol 169:2354-2360. (Pubitemid 34920976)
61. Xie QW, Kashiwabara Y, Nathan C. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708. (Pubitemid 24239438)
62. Yoshida H, Miyazaki Y. 2008. Regulation of immune responses by interleukin-27. Immunol Rev 226:234-247.
63. Zhong H, May MJ, Jimi E, Ghosh S. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625-636.
64. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671. (Pubitemid 128379244)